Huadong Medicine Co (SZSE:000963) EV-to-Revenue : 1.37 (As of May. 05, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Huadong Medicine Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Huadong Medicine Co's enterprise value is ¥56,120 Mil. Huadong Medicine Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥40,920 Mil. Therefore, Huadong Medicine Co's EV-to-Revenue for today is 1.37.

The historical rank and industry rank for Huadong Medicine Co's EV-to-Revenue or its related term are showing as below:

SZSE:000963' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.66 Med: 1.55 Max: 2.69
Current: 1.37

During the past 13 years, the highest EV-to-Revenue of Huadong Medicine Co was 2.69. The lowest was 0.66. And the median was 1.55.

SZSE:000963's EV-to-Revenue is ranked better than
70.7% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 2.36 vs SZSE:000963: 1.37

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-05), Huadong Medicine Co's stock price is ¥32.94. Huadong Medicine Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥23.36. Therefore, Huadong Medicine Co's PS Ratio for today is 1.41.

Huadong Medicine Co EV-to-Revenue Historical Data

The historical data trend for Huadong Medicine Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huadong Medicine Co EV-to-Revenue Chart

Huadong Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

1.20

1.36

1.98

2.15

1.73

Huadong Medicine Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															2.08	1.87	1.81	1.73	1.30

Competitive Comparison of Huadong Medicine Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Huadong Medicine Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huadong Medicine Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huadong Medicine Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Huadong Medicine Co's EV-to-Revenue falls into.

Huadong Medicine Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Huadong Medicine Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	56119.885	/	40920.06
	=	1.37

Huadong Medicine Co's current Enterprise Value is ¥56,120 Mil.
Huadong Medicine Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥40,920 Mil.

Huadong Medicine Co (SZSE:000963) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Huadong Medicine Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	32.94	/	23.363
	=	1.41

Huadong Medicine Co's share price for today is ¥32.94.
Huadong Medicine Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥23.36.

Huadong Medicine Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Huadong Medicine Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Huadong Medicine Co (SZSE:000963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huadong Medicine Co Ltd (SZSE:000963) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

468 Yan’an Road, Floor 7, 9 and 10, Gate No. 1, Building No. 1, Hangzhou, CHN, 310006

Website

http://www.eastchinapharm.com

Huadong Medicine Co Ltd is engaged in the production and sales of antibiotics, proprietary Chinese medicine, chemical synthetic medicine and genetic engineering drugs products. It is also engaged in the wholesale, retail and distribution business of Chinese and western medicine, Chinese herbal medicine, medical apparatus, and instruments. The main business of the company is divided into pharmaceutical business sales and the industry of pharmaceutical. The product portfolio of the company includes Corbrin capsule, Cymusi, New Cyspin, Kasiping, Panlisu, Acarbose, and others.

Huadong Medicine Co (SZSE:000963) Headlines

No Headlines